bpc-157 for herniated disk Does Help With Sciatica? What the Research Says Drew Timmermans, ND, RMSK |
Description
Martin TG, Corzo K, Chiron M, Velde Hvd, Abbadessa G, Campana F
Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist currently in Phase 3 trials
The single most important takeaway: if you have active cancer, are pregnant, or are under 18, no research peptide has sufficient safety data to justify use
This is because injections bypass the entire digestive system
